Alnylam Pharmaceuticals
ALNY
#1111
Rank
C$30.49 B
Marketcap
C$227.69
Share price
5.41%
Change (1 day)
-64.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company